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1. Introduction 
Polymerase chain reaction (PCR) amplification provides a powerful tool for parasite 
detection. This chapter examines the use of PCR to diagnose malaria in patients with low 
parasite densities (submicroscopic infections, SMI) and also occult loaiosis (OL: Loa loa 
infection without detectable circulating microfilaria on standard microscopy). It provides 
therefore the issue of management of these kinds of infections with regard to the eradication 
policy of such pathogens.   
1.1 Classification 
i. Malaria: Malaria is caused by Plasmodium parasites, of which there are about 200 
species (Levine ND 1980). These protozoans belong to the Apicomplexa phylum, Sporozoa 
class and Haemosporidae subclass (Levine ND 1970). They are obligatory intracellular 
parasites.  Two successive hosts, humans and mosquitoes (Culicidea and Anophelinea), 
are necessary for their life cycle. Four main species infect humans, namely Plasmodium 
falciparum, P. vivax, P. malariae and P. ovale. A fifth species, P. knowlesi, is currently 
spreading in south-east Asia and Oceania. This species derived from chimpanzees has 
caused more than 250 human cases of malaria in Malaysia but is still considered to be 
zoonotic (Figtree et al. 2010). P. falciparum causes most life-threatening infections.  
Human is the intermediate host for malaria, wherein the asexual phase of the life cycle 
occurs. The sporozoïtes, inoculated by the infested female Anopheles mosquito, initiate 
this phase of the cycle from the liver, and continue within the red blood cells. From the 
mosquito bite, tens to few hundred invasive sporozoïtes are introduced into the skin. 
Following the intradermal drop, some sporozoïtes are destroyed locally by the immune 
cells, or enter into the lymphatic vessels, and some others can find blood circulation 
(Megumi L et al. 2007; Ashley M et al. 2008; Olivier S et al. 2008). The sporozoïtes that 
find peripheral blood circulation reach the liver within a few hours. It has been recently 
demonstrated that these sporozoïtes travel by a continuous sequence of stick-and-slip 
motility, using the thrombospondin-related anonymous protein (TRAP) family and an 
actin–myosin motor (Baum J et al. 2006; Megumi L et al. 2007; Münter S et al. 2009). The 
sporozoites migrate into hepatocytes and then grow within parasitophorous vacuoles 
and develop to the schizont stage which releases merozoites (Jones MK et al. 2006; 
Kebaier C et al. 2009). The entire pre-eryhrocytic phase lasts about 5–16 days depending 
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on the parasite species (5-6 days for P. falciparum, 8 days for P. vivax, 9 days for P. ovale, 
13 days for P. malariae and 8-9 days for P. knowlesi. The pre-erythrocytic phase remains a 
“silent” phase, with little pathology and no symptoms, as only a few hepatocytes are 
affected (Ashley M et al. 2008). This phase is a single cycle, contrasting to the next, 
erythrocytic stage, which occurs repeatedly. 
ii. Loaiosis: Filariasis are typically chronic tropical diseases caused by nematodes of the 
Filariidae family, transmitted by flies or mosquitoes. Eight species are currently known 
to infect humans, namely Wuchereria bancrofti, Brugia malayi, B. timoni, Onchocerca 
volvulus, Loa loa, Mansonella perstans, M. ozzardi, and M. streptocerca. Three groups of 
filariasis have been distinguished on the basis of their human target tissues: lymphatic 
filariasis (wuchereriasis and brugiasis); cutaneous dermal filariasis (loaiosis, 
onchocerciasis, and streptocerca mansonelliasis) and serous filariasis (perstans and ozzardi 
mansonelliasis) (Gentilini 1982). The vectors are blood-sucking flies and female 
mosquitoes. The microfilarial eggs or embryos are ingested by the vector when it bites 
an infected human. These microfilariae become infective stage L3 larvae after two 
successive mutes within the vector, and are transmitted to a new human host through a 
new blood meal or bite.  
More than 3.3 billion people are exposed to filariosis, and an estimated 300 million people 
are infected. Loaiosis occurs in Africa, brugiaioses in South Asia, wuchereriasis in Africa 
and Asia, onchocerciasis in Africa, Central and South America and Asia (Yemen), perstans 
mansonelliasis in Africa and Central and South America, ozzardi mansonelliasis in Central 
and South America, and streptocerca mansonellaiosis in Africa. 
L. loa infection (loaiosis) was initially described in 1770 by Mongin, in a female slave 
originating from West Africa and living on Saint Domingue island. Guyon et al. found the 
same worm in Gabon (Central Africa) in 1864. L. loa was first described in detail by Brumpt 
et al. in 1904, and then by Connors et al. in 1976. Although discovered in the Antilles, L. loa is 
restricted to Africa (Gentilini 1982). The adult worms live under the skin for about 15 years 
(Gentilini et al. 1982). The tabanides responsible for L. loa transmission are primarily 
Chrysops dimidiata and silacea, two forest species often present in the same hearth. Only the 
females are hematophagous, and they have diurnal activity.  
1.2 Pathogenesis 
i. Malaria: P. falciparum is responsible for most complicated forms of malaria and causes 
about 800 000 deaths a year, mostly among children in sub-Saharan African countries 
(WHO 2009). Malaria symptoms generally occur in three phases. After an incubation 
period of 7 to 10 days, symptoms begin with fever, aches and digestive disorders 
(febrile stomach upset). Then, when schizont rupture becomes synchronous, patients 
enter the feverish reviviscent schizogonic phase (periodic fever) of uncomplicated 
malaria. This phase is characterized by fevers typically appearing every 24 hours (third 
fever in infection by P. vivax or ovalae, every 48 hours, quartan fever in infection by P. 
malariae or P. falciparum), accompanied by a triad of symptoms: shivers, fever and 
sweating. Destruction of parasitized red blood cells leads to the release of malarial 
toxins and to TNF alpha production. The third phase, mainly seen with P. falciparum, 
corresponds to severe malaria (pernicious access), which sometimes occurs rapidly after 
infection. Clinical and biological signs are used to classify malaria (WHO 2000 gravity 
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criteria, Imbert et al 2002). The reasons why some non immune individuals infected by 
P. falciparum develop severe malaria and die, while others have only uncomplicated 
malaria or remain asymptomatic, remain unclear (Marsh et al 1988). Severe anemia and 
cerebral malaria are responsible for most of the morbidity and mortality related to this 
disease in children. Despite abundant research, the pathophysiological mechanisms 
underlying severe forms are poorly understood. Several studies have implicated 
sequestration of P. falciparum-parasitized red blood cells (PRBC) in the lungs and brain 
(Taylor et al. 2001). This sequestration is characterized by PRBC adhesion (or 
cytoadherence), agglutination and rosetting. Cytoadherence of PRBC to host endothelial 
cells (EC) in brain and lung capillaries can obstruct the microvasculature, a 
phenomenon accompanied by changes in the T cell repertoire and by cytokine 
production (Mazier et al. 2000). This adherence is modulated by platelets (Brown et al. 
2000) and is mediated by EC receptors such as CD36, intracellular adhesion molecule 1 
(ICAM1), vascular cellular adhesion molecule 1 (VCAM1), CD31, integrins and 
hyaluronic acid (Hunt et al. 2003). PRBC adhesion can induce over-expression of 
inflammatory cytokines (Mazier et al. 2000) and EC apoptosis (Pino et al. 2003). 
Approximately 20% of P. falciparum isolates from Franceville, Gabon (Central Africa), 
were show to induce human lung endothelial cell (HLEC) apoptosis by cytoadherence 
(Touré et al. 2008). In addition, apoptogenic isolates were more frequent in children 
with neurological signs (prostration or coma), supporting the hypothesis that PRBC-
mediated EC apoptosis could amplify blood-brain barrier disruption and dysfunction 
(Combes et al. 2005; Bisser et al. 2006).  Whole transcriptome analysis revealed that 59 
genes were more intensely transcribed in apoptogenic strains than in non apoptogenic 
strains (Siau et al. 2007). Knock-down of 8 of these genes by double-strand RNA 
interference significantly reduced the apoptogenic response in 5 genes (PF07_0032, 
PF10255, PFI0130c, PFD0875c, and MAL13P1.206). These five genes are known as 
Plasmodium apoptosis-linked pathogenicity factors (PALPF).  
ii. Loaiosis: Loaiosis is characterized by calabar oedema (swelling) and conjunctivitis due 
to ocular passage of adult worms. Calabar oedema is transient and located on the face, 
limbs and back of the hands and fingers. L. loa is also called the "African eye worm”. 
Meningoencephalic complications are an adverse effect of diethylcarbamazine 
treatment for hypermicrofilaremia. Other complications such as nephropathies, 
endocarditis, retinopathies, neuropathies and pneumonitis have been reported 
(Schofield et al. 1955; Hulin et al. 1994). Symptoms are more frequent in expatriates. 
Immunologically, loaiosis is characterized by hypergammaglobulinemia, 
hypereosinophilia and high IgE levels responsible for allergic symptoms.  In endemic 
areas, loaiosis is the third reason for medical consultations in rural settings, although 
many microfilaremic subjects are asymptomatic. Occult loaiosis (amicrofilaremic 
infection) is defined as infection by the adult worm without peripheral microfilaremia 
on standard microscopy. Amicrofilaremic status is common among autochthonous 
residents and may be due to sequestration of microfilaria or to their massive 
destruction by the immune system, or to the presence of sterile adult worms. This 
form of infection is the most common in endemic areas. Other amicrofilaremic 
subjects are thought to be resistant. There is currently no way of discriminating 
between these two amicrofilaremic subgroups in the absence of (transient) ocular 
passage of adult worms.  
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1.3 Diagnostic challenges  
i. Malaria: Light microscopy of blood smears remains the standard method for 
Plasmodium detection, both for clinical diagnosis and epidemiological surveys (Okell LC 
et al. 2009). However, sensitivity depends on parasite density in blood. In patients with 
low parasitemia, mixed infections, antimalarial treatment or chronic infection, 
microscopic diagnosis requires painstaking examination by an experienced technician. 
Low-density infections that cannot be detected by conventional microscopy are termed 
submicroscopic infections (SMI). Plasmodium species identification is mainly based on 
microscopic morphological characteristics but this is not entirely reliable (Plasmodium 
vivax resembles P. ovale). In addition, parasite morphology can be altered by drug 
treatment and/or sample storage conditions.   
ii. Loaiosis: Human loaiosis differs from other filariasis by the fact that most patients have 
“occult” infection, with no circulating microfilaria. This peripheral amicrofilaremia can 
be due to microfilaria destruction by the immune system, and/or to their sequestration. 
These subjects cannot be diagnosed by microscopy and consequently go untreated, 
constituting a parasite reservoir. Before 1997, L. loa diagnosis was still based on 
microscopic examination and the prevalence was therefore underestimated. In contrast, 
because of cross-reactions, serological tests, and especially those based on total IgG 
detection, tend to overestimate prevalence. The existence of many cases of occult but 
symptomatic infection among residents in endemic areas implies the need for specific 
and sensitive detection.  
2. PCR-based diagnosis of malaria  
In 1993 a PCR method targeting the small subunit of the ribosomal RNA (SSUrRNA) gene 
was developed for use as an alternative to microscopy for detecting the four main 
Plasmodium species (Snounou et al. 1993, 1994, 1995). Nested PCR was used for its high 
sensitivity and specificity (Snounou et al. 1993). However, the nested reaction requires five 
separate PCR reactions and is therefore time-consuming, expensive and not always feasible 
in developing world laboratories. Several variants of this nested PCR method, such as semi-
nested multiplex and one-tube multiplex have been developed (Mixon-Hayden T et al. 
2010). In 1998 Jarra and Snounou showed that Plasmodium DNA is cleared very quickly from 
the bloodstream and that positive PCR amplification is usually associated with the presence 
of viable parasites. PCR positivity therefore indicates active Plasmodium infection. Since 
1997, several PCR methods targeting other P. falciparum genes have been developed (Cheng 
et al. 1997; Filisetti et al. 2002). Their sensitivity has been estimated at 71%, 83% and 100% for 
the MSP-2, SSUrRNA and STEVOR genes, respectively (Oyedeji et al. 2007).  
Real-time PCR has been reported to be able to improve parasite detection. Compared to 
SSUrRNA nested PCR, the real-time assay had a sensitivity of 99.5% and specificity of 100% 
for the diagnosis of malaria (Farcas GA et al. 2004). The real-time PCR method, specific for 
all Plasmodium species, avoids post-amplification sample handling and electrophoresis, and 
the result can be ready within 45 min (Farcas GA et al. 2004). This method would be useful 
for monitoring antimalarial drug efficacy, especially in areas of drug resistance (Lee MA et 
al. 2002). 
More recently, it has been shown that dot18S (18SrRNA gene) and CYTB, two new 
molecular methods, are highly sensitive and allow high-throughput scaling up for many 
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hundred samples (Steenkeste N et al. 2009). The CYTB is a nested PCR based on 
Plasmodium cytochrome b gene followed by species detection using SNP (single nucleotide 
polymorphism) analysis. The usefulness of these methods in detecting malaria has been 
demonstrated especially in low endemic areas.   
2.1 Materials and methods 
a. Blood sampling 
Samples must be collected in sterile tubes. For example, peripheral blood is collected in 
tubes containing an anticoagulant such as EDTA. However, some anticoagulants, such 
as heparin, inhibit the action of Taq DNA polymerase and should thus be avoided. 
Blood samples can also be collected in the form of drops on calibrated pre-punched 
paper disks (Serobuvard, LDA 22H, Zoopole, Ploufragan, France) (Ouwe-Missi-
Oukem-Boyer et al. 2005). 
b. Microscopy  
Thick and thin peripheral blood films were stained with Giemsa and examined by 
microscope. For microscope positive samples, the parasite load is expressed as the 
number of asexual forms of P. falciparum/µL of blood, assuming an average leukocyte 
count of 8000/µL.  
c. DNA template preparation 
There are many useful techniques for DNA template processing. Plasmodial DNA 
extraction involves erythrocyte lysis and proteinase K digestion to prevent PCR 
inhibition. 
i. DNeasyR Blood & Tissue Kit: Whole blood (200 µl) is used for DNA extraction 
with the DNeasy Blood & Tissue kit (QIAGEN, Hilden, Germany). Briefly, DNA 
extraction is carried out as follows. To a 1.5-ml tube containing 200 µl of while 
blood are added 20 µl of proteinase K solution and 200 µl of AL buffer (a detergent 
included in the kit). The mixture is pulse vortexed for 15 seconds and incubated for 
15 minutes at 56°C. Two hundred microliters of cold ethanol is then added and the 
mixture is vortexed for 15 seconds. The mixture is transferred to a mini-column 
assembled on a 2-ml tube and centrifuged for 1 min at 8000 rpm. After 
centrifugation the 2-ml tube is discarded OK. The mini-column is recovered and 
placed on a new 2-ml tube. The mini-column is then washed with 500 µL of AW1 
buffer (available in the kit) by centrifugation at 8000 rpm for 1 min. This washing 
step is repeated with another 500 µL of AW2 buffer, followed by centrifugation for 
3 min at 14 000 rpm. The 2-ml tube is again discarded. 
The mini-column is placed on a 1.5-ml tube and 60 µl of AE elution buffer is added. 
This unit is left at room temperature for 10 min and then centrifuged for 1 min at 
8000 rpm. The DNA is then recovered in the 1.5-ml tube and immediately used as a 
template or stored at 20°C.  
ii. Dried blood-spot method (DBS): DNA templates are extracted as described by 
Plowe CV et al in 1995. The dried blood spot is placed in 1 ml of phosphate 
buffered saline (PBS) containing 0.5% saponin and is incubated overnight at 4°C. 
The resulting brown solution is replaced with 1 ml of PBS and incubated for an 
additional 15-30 minutes at 4°C. Then, 200 µl of 5% Chelex 100 (Bio-Rad 
Laboratories, CA) is placed in clean tubes and heated to 100°C in a water bath. The 
disks are removed from the PBS and placed in the preheated 5% Chelex 100, 
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vortexed at high speed for 30 seconds and placed in a water bath at 100°C for 10 
minutes with gentle agitation. The samples are then centrifuged at 10 000 g for 2 
minutes, and the supernatant is removed and centrifuged as before. The 
supernatant is then collected in a clean tube and immediately used for PCR or 
stored at 20°C until use. 
DNA can be also extracted from dried blood spots with several other methods, such as the 
QIAamp® DNA Mini Kit (QIAGEN, Hilden, Germany).  
2.2 P. falciparum DNA amplification and detection 
i. SSUrRNA gene amplification 
Two microliters of DNA extract is amplified in a final volume of 25 μl containing 2.5 μl of 
10X reaction buffer, 100 μM each dNTP (dATP, dGTP, dTTP, and dCTP), 0.5 pM each 
primer (rPLU5/rPLU6 (rPLU5 5'-CCT GTT GTT GCC TTA AAC TTC-3' and rPLU6 5'-TTA 
AAA TTG TTG CAG TTA AAA CG-3') for the primary reaction, and rFAL1/rFAL2 (rFAL 1 
5'-TTA AAC TGG TTT GGG AAA ACC AAA TAT ATT-3' and rFAL 2 5'-ACA CAA TGA 
ACT CAA TCA TGA CTA CCC GTC-3') for the nested reaction) and 0.75 units of Taq DNA 
polymerase (QIAGEN, Hilden, Germany). The primer sequences (Table 1) are based on 
SSUrRNA sequences described elsewhere (Snounou et al. 1993). The PCR program is as 
follows: denaturation at 95°C for 5 min followed by 25 cycles (30 cycles in nested PCR) at 94°C 
for 1 min, 60°C for 2 min and 72°C for 2 min, with a final extension step of 5 min at 72°C. 
ii. STEVOR gene amplification 
The first round of amplification is performed with a reaction mix of 50 μl containing 5.0 μl of 
10X reaction buffer, 200 μM each dNTP (dATP, dGTP, dTTP, and dCTP), 1.25 units of Taq  
 
Schema 1. Schematic representation of the STEVOR PCR methodology (CHENG et al 1997). 
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DNA polymerase, 0.4 pM each primer (P5, P18, P19 and P20) (P5 5'-GGG AAT TCT TTA 
TTT GAT GAA GAT G-3', P18 5'-TTT CA(C/T) CAC CAA ACA TTT CTT-3', P19 5'-AAT 
CCA CAT TAT CAC AAT GA-3', P20 5'-CCG ATT TTA ACA TAA TAT GA-3') and 5 μl of 
DNA template. The PCR program is as follows: denaturation at 93°C for 3 min followed by 
25 cycles of 30 s at 93°C, 50 s at 50°C and 30 s at 72°C, with a final extension step of 3 min at 
72°C. Two microliters of the first-round PCR product is used for the second round of 
amplification, with a reaction mixture of 50 μl containing 5.0 μl of 10X reaction buffer, 200 
μM each dNTP, 1.25 units of Taq DNA polymerase and 0.4 pM each primer (P17 and P24) 
(P17 5'-ACA TTA TCA TAA TGA (C/T) CC AGA ACT-3', P24 5'-GTT TGC AAT AAT TCT 
TTT TCT AGC-3'). The PCR conditions for the nested reaction are as follows: denaturation at 
93°C for 3 s, followed by 25 cycles of 30 s at 93°C, 50 s at 55°C and 30 s at 72°C, with a final 
extension step of 3 min at 72°C. 
iii. Detection procedures 
Analysis of PCR products: After amplification, 10 µl of each PCR product is mixed with 1 µl 
of loading dye (0.25% bromophenol blue, 0.25% xylene cyanol and 40% w/v sucrose in 
water) and analyzed by electrophoresis on 1.5% agarose gel. The gel is stained with 
ethidium bromide or FluoProbes Gel Red (Interchim Montlucon, France) and the DNA is 
visualized and photographed under ultraviolet light. 
Plasmodium SSUrRNA gene: 
 
Fig. 1. Detection and speciation of Plasmodium by nested PCR using genus-specific primers 
and 1.5% agarose gel electrophoresis. Lanes 1 and 8: PCR-negative controls; lane 2: an 
individual with submicroscopic infection by P. malariae (size: 144 base pairs); lanes 3, 5, 7 
and 10: PCR-negative individuals; lanes 4, 6, 9 and 11: individuals with submicroscopic co-
infection with P. falciparum (size: 205 bp) and P. malariae. Lane M represents the DNA 
molecular weight marker (100 bp). 
P. falciparum STEVOR gene  
Theoretically, three specific bands between 189-700 base pairs are generated using nested 
primers. We obtained a specific band of 250 bp for all P. falciparum isolates tested in 
Franceville, southeastern Gabon.  
M     1   2    3    4    5     6    7    8    9   10    11 
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Fig. 2. Detection of the Plasmodium STEVOR gene by nested PCR using specific primers and 
1.5% agarose gel electrophoresis. Lanes 1 and 10: PCR-negative controls; lanes 2, 3, 4, 6, 8, 9 
and 11: PCR-negative samples; lanes 5 and 7: PCR-positive samples; lane 12: PCR-positive 
control; lane M: DNA molecular weight marker (123 bp). 
3. PCR based diagnosis of Loa loa  
In 1997, a PCR method (15r3-PCR) was developed to detect the repeat 3 region of the gene 
encoding the L. loa polyprotein in blood samples (Touré et al. 1997a, 1997b). Amicrofilaremic 
status is generally due to massive destruction of microfilaria, releasing parasite DNA into 
the bloodstream. These molecules may exist free in plasma, or be associated with cell-
surface proteins, or even be contained in phagocytic cells. In addition, the adult worms can 
release DNA when they produce nonviable eggs or when they die after immune attack. The 
quantity of DNA released, whether from eggs, microfilaria or adult worms, is related to the 
parasite load of adult worms. The 15r3-PCR assay had a sensitivity of 95% with respect to 
detection of ocular passage of L. loa adult worms, and 100% compared to detection of 
microfilaremia.  
3.1 Materials and methods 
a. Blood sampling 
As previously mentioned blood samples must be collected by venipuncture into 
Vacutainer tubes containing an adequate anticoagulant such as EDTA. 
b. Leukoconcentration 
Clinically, L. loa infection is diagnosed when migration of adult worms under the 
conjunctiva and/or skin is observed, or when a patient presents with classical 
symptoms. Diagnosis is classically based on standard microscopy. Microfilariae are the 
blood stage of L. loa. One milliliter of each blood sample is added to a 15-ml tube 
containing 9 ml of phosphate buffered saline (PBS), in duplicate. The mixture is treated 
with 600 µl of 2% saponin at room temperature for 15 min to lyse red blood cells, 
followed by centrifugation at 1000 g for 15 minutes at 4°C. The supernatant is discarded 
and the pellet is examined microscopically for microfilariae. The distinction between L. 
M    1   2    3    4     5     6    7    8  9  10   11  12 
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loa and M. perstans microfilariae is based on size, motility, and by the presence of a 
sheath (L. loa).  
Thick smears can be also prepared with venous blood and stained with Giemsa or 
hematoxylin-eosin to detect microfilariae. The QBC (Quantitative Coating Buffer) 
method is also used to detect L. loa microfilariae. 
For microscopic detection of L. loa microfilariae, blood samples must be collected 
during the day, given the diurnal periodicity of human loaiosis.  
c. Whole blood lysate processing 
Whole blood (100 µl) is mixed with 500 µl of TE buffer (10 mM Tris pH 8; 0.1 mM EDTA 
pH 8) and spun at 10 000 g twice for 2 min, discarding the supernatant at each step. The 
pellet is resuspended in 500 µl of sucrose buffer (10 mM Tris pH 7.6, 5 mM MgCl2 1 M 
sucrose and 1% Triton X 100) and spun at 10 000 g twice for 2 min. After the final wash, 
the supernatant is discarded and the pellet is resuspended with 200 µl of prewarmed 
(56°C) proteinase K buffer (containing 20 mM Tris pH 8, 50 mM KCl, 2.5 mM MgCl2, 
100 µg/ml proteinase K and 0.5% Tween20), incubated at 56°C for two hours, then held 
at 90°C for 10 min. The DNA can be stored at 4°C for several days or at -20°C until 
required. 
d. L. loa 15r3 gene amplification and detection 
Primers corresponding to the 5' and 3' ends of the repeat 3 sequence of the gene coding 
for L. loa 15 kDa allergenic polyprotein are used. Primary amplification is done with a 
reaction mixture of 50 µl containing 2 µl of blood lysate, 1X PCR buffer (supplied by the 
manufacturer: 200 mM Tris-HCl pH 8.7, 100 mM KCl, 100 mM (NH4)2SO4, 20 mM 
MgSO4, 1% Triton x100, 1 mg/ml bovine serum albumin), 200 µM each dATP, dCTP, 
dGTP and dTTP, 1 µM each primer (15r3-1: 5’-AAT-CAG-GCA-AAT-AAT-GGC-ACA-
AAA-3’, 15r3-2: 5’-GCG-TTT-TCT-TCT-CAC-CAG-CTG-TCT-3’) and 1 unit of DNA 
polymerase. Amplification is performed with a Perkin Elmer thermal cycler for 40 
cycles: 94°C for 1 min (denaturation), 65°C for 1 min (annealing) and 72°C for 2 min  
 
Fig. 3. Representative 1.5% agarose gel electrophoresis patterns of nested 15r3 PCR 
products.  Lanes 1, 2 and 7: L. loa amicrofilaremic individuals (AMF) positive by PCR. Lanes 
4 and 5: individuals negative by PCR. Lane 8: an individual with 100 L. loa microfilariae per 
ml and positive by PCR. Lanes 3 and 6: PCR-negative controls (no template); 5 µl of each 
nested PCR product was applied to each lane and revealed using UV transillumination after 
ethidium bromide staining. A fragment of 366 bp was observed with positive samples. Lane 
M: DNA molecular weight marker VI (Boehringer). 
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(extension), preceded by a ”hot start” cycle at 96°C for 10 min, 80°C for 5 min and 94°C 
for 30 s. One microliter of product from the first-round amplification is used for a 
second round in the above conditions for 30 cycles. The following primers are used: 
15r3-3: 5’GGC ACA AAA CAC TGC AGC AGT CCT3’, and 15r3-4: 5’CAG CTG TCT 
CAA ATC GAA GAT TCT 3.’ 
4. Submicroscopic infection and disease management and control 
i. Malaria:  
The global strategy for malaria control is based on prevention, early diagnosis and prompt 
treatment. The detection limit of routine microscopy has been estimated to be about 100 
parasites/milliliter, whereas PCR can detect as little as 0.01 parasite /micro liter 
(Mockenhaupt FP et al. 2002). Submicroscopic infection (SMI) including submicroscopic 
gametocytes is common in both symptomatic and asymptomatic individuals with malaria. 
A systematic review and analysis of field data carried out by Okell LC et al. in 2009 showed 
that the prevalence of P. falciparum was twice as high with PCR as with microscopy. In a 
village in Dienga, southeastern Gabon, PCR was performed on blood samples from 
asymptomatic individuals negative by microscopy: the prevalence of SMI (PCR positivity) 
was 13.7% by PCR and 7.2% by microscopy (Touré et al. 2006). A study carried out by 
Bouyou-Akotet et al. in 2010 in Libreville (capital of Gabon) showed an 18.2% prevalence of 
SMI in pregnant women. Recently, SMI was detected in 18% of symptomatic individuals in 
Franceville, southeastern Gabon, whereas the microscopic prevalence was 23% (author’s 
personal data). It has been estimated that as many as 88% of infections remain undetectable 
by microscopy in low-transmission areas, where the PCR prevalence is generally under 10% 
(Okell LC et al. 2009). Thus, a high rate of SMI could undermine disease control programs. 
In endemic areas, it has been shown that P. falciparum SMI contributes to acute disease 
(Rogier C et al. 1996), and to malaria-associated anemia and inflammation (Mockenhaupt FP 
et al. 2002). It has also been shown that cerebral malaria is frequently associated with SMI in 
semi-immune individuals (Giha HA et al. 2005). Finally, Bouyou-Akotet et al. 2010 have 
demonstrated that SMI during pregnancy is associated with low birth weight, especially in 
primagravidae. As parasite resistance to antimalarial drugs is currently widespread and 
increasing, it is very important to identify resistant parasites in patients with SMI. Two 
major genes have been implicated in P. falciparum resistance to quinoline, namely Pfcrt (P. 
falciparum chloroquine resistance transporter) and Pfmdr1 (P. falciparum multidrug resistance 
gene 1). Single-nucleotide polymorphisms (SNPs) in these genes are associated with 
resistance both in vitro and in vivo (Wongsrichanalai et al. 2002). Therefore, P. falciparum 
drug resistance is linked to particular parasite genotypes (Duraisingh et al. 1997). P. 
falciparum infection is generally polyclonal, and may thus involve both drug-sensitive and 
resistant genotypes. SMI detection can be used to evaluate the therapeutic effectiveness of 
anti-malarial drugs during mass treatments and preclinical trials. 
SMI individuals are capable of infecting mosquitoes and contributing to human 
transmission (Coleman RE et al. 2004), mainly in areas of seasonal transmission (Nwakanma 
D et al. 2008). Microscopy fails to detect the parasite in 49.2% of all malaria cases and in 
91.3% of gametocytemic individuals (Okell LC et al. 2009). Individuals whose blood smears 
are negative for gametocytes (submicroscopic gametocyte) are equally able to transmit the 
infection to mosquitoes as slide-positive individuals (Coleman RE et al. 2004). Thus, the SMI 
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gametocyte reservoir may sustain malaria transmission despite efforts to fight malaria in 
endemic areas (Karl S et al. 2011). The prevalence of SMI, including submicroscopic 
gametocytes, must be assessed and taken into account in malaria control programs (Okell 
LC et al. 2009, Karl S et al. 2011).  
Only patients with positive blood smears and/or rapid diagnostic tests (RDT) are routinely 
treated, while the treatment of patients negative by both methods depends on clinical signs 
and the physician’s appreciation. These patients, including those with SMI, may represent 
more than 10% of infected individuals. In Gabon, SMI currently tends to be more frequent 
than microscopic infection, possibly due to better preventive policies and/or case 
management (Bouyou-Akotet et al. 2010). Treatment of all infected subjects, including those 
with SMI and submicroscopic gametocytes, would reduce the community parasite burden. 
Indeed, it has been shown that intermittent preventive treatment can reduce the prevalence 
and genetic diversity of P. falciparum malaria (Liljander A et al. 2010).  
ii. Loa loa  
Human loaiosis differs from other filariasis by the fact that most infected individuals do not 
have blood microfilariae detectable by standard microscopy. Since the first description of 
this filariasis, many epidemiologists have found a low prevalence of microfilaria despite 
local vector abundance. The notion that most patients clear their microfilaremia but 
continue to have (occult) infection is primarily based on the observation of adult worms 
during eye passage. The assumption that endemic resistant subjects also may exist (subjects 
able to completely eliminate L. loa infection) is still based on the same observations. Only a 
sensitive diagnostic test can confirm these assumptions. Our results have shown that 15r3-
PCR is suitable for discriminating among endemic groups (microfilaremics, occult infected 
individuals (occults) and resistant subjects), as the results should be positive in the first two 
groups and negative in the last. Indeed, two-thirds of infected individuals in southeastern 
Gabon have occult loaiosis (OL) Touré et al. (1998, 1999a). This needs to be shown in a 
longitudinal study, however, as L. loa infection is characterized by its relative stability in 
humans and mandrills, the adult worm having a lifespan of about 15 years (Gentillini 1982, 
Pinder 1994). 
This implies that the prevalence of loaiosis would be underestimated by microscopy. If L. loa 
DNA detection is a marker of active infection, all subjects positive by PCR should be treated. 
This would not have a major impact on health at the individual level but could reduce the 
parasite burden in the community, in turn reducing the intensity of transmission and 
resulting in public health benefits.  
Studies of resistant individuals may provide interesting immunological information. 
Marked differences in humoral and cellular immune responses have already been noted 
between microfilaremic and amicrofilaremic patients (Pinder 1988, Akué 1997, Baize et al. 
1997), as well as in the mandrill model (Leroy 1997). However, lacking a reliable method for 
diagnosing occult infection, it is not known if this difference is due to immunity directed 
against adult worms or against microfilaria. The identification of endemic groups 
(“microfilaremics”, “occults” and “resistants”) by 15r3-PCR method should allow 
immunological studies to be carried out with sera and cells from each endemic group, using 
antigens of each developmental stage of L. loa, and particularly infective larvae and adult 
worms. Such studies could help to identify possible cellular or humoral markers involved in 
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resistance to infection, as well as the underlying mechanisms, including host genetic factors. 
These studies would open the way to investigations of the underlying molecular 
mechanisms.  
In addition, the detection of OL by PCR will allow precise evaluation of filaricide 
effectiveness during mass treatment, and also that of new drugs in animal models. Pinder et 
al. showed in 1994 that experimental mandrill infection (Mandrillus sphinx) by human L. loa 
isolates led to the same parasitologic characteristics as the natural human infection. Thus, 
mandrills with occult infection (absence of microfilarae but presence of adult worms, as 
shown by 15r3-PCR positivity; Touré et al. 1998) can be used to evaluate macrofilaricidal 
drugs. It has been demonstrated that the 15-kDa polyprotein is conserved within human 
and simian L. loa (Touré et al. 1999b). L.15r3-PCR also detects simian occult L. loa and could 
be used to identify infected animals before their inclusion in preclinical trials.  
Finally, serological tests using purified recombinant antigens or peptides offer much better 
specificity than those using crude antigens. When these antigens become available for 
loaiosis, immunoenzymatic methods like IgG4 ELISA will reach acceptable specificity. 
Comparison of ELISA and PCR results sould show whether or not specific IgG4 antibodies 
are markers of active L. loa infection.  
5. Conclusion 
The global strategy of eliminating the parasitic diseases especially malaria and filariasis is 
mainly based on prevention, early diagnosis and prompt treatment. However, most 
decisions still rely on microscopy diagnosis which is not always adapted in detecting all 
infections. Indeed, the success of any intervention depends of the effectiveness of tools and 
methods especially those allowing proper detection of parasites. PCR offers an exciting 
opportunity to diagnose submicroscopic malaria infections and occult loaiosis which may 
constitute a hidden reservoir of disease transmission. The detection of such infections would 
allow the accurate management of all cases necessary to progress from disease control to 
elimination.  
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